Short-term effects of pulmonary rehabilitation on asthma control in patients with moderate-severe unstable asthma

T. Schneeberger (Marburg, Germany), J. Gebhardt (Marburg, Germany), I. Jarosch (Marburg, Germany), R. Gloeckl (Munich, Germany), M. Boensch (Marburg, Germany), C. Taube (Essen, Germany), K. Kenn (Marburg, Germany), R. Koczulla (Marburg, Germany)

Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Session: Hot topics in pulmonary rehabilitation
Session type: Poster Discussion
Number: 3415
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Schneeberger (Marburg, Germany), J. Gebhardt (Marburg, Germany), I. Jarosch (Marburg, Germany), R. Gloeckl (Munich, Germany), M. Boensch (Marburg, Germany), C. Taube (Essen, Germany), K. Kenn (Marburg, Germany), R. Koczulla (Marburg, Germany). Short-term effects of pulmonary rehabilitation on asthma control in patients with moderate-severe unstable asthma. 3415

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Long-term benefits of pulmonary rehabilitation in patients with chronic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 454s
Year: 2002

Effects of pulmonary rehabilitation in asthma patients
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017

Effects of pulmonary rehabilitation in patients with asthma
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018




Severe outcomes of COVID-19 among patients with COPD and asthma
Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Year: 2021



Mild improvement in symptoms and pulmonary function in a long-term follow-up of patients with TDI-induced asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 604s
Year: 2005

Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020


Effect of asthma and asthma medication on the prognosis of patients with COVID-19
Source: Eur Respir J, 57 (3) 2002226; 10.1183/13993003.02226-2020
Year: 2021



Comparing the effects of pulmonary rehabilitation in patients with uncontrolled and partially controlled asthma
Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Year: 2018



Continuous objective assessment of wheezing in adult asthma patients hospitalised following an acute exacerbation of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 267s
Year: 2001

Additive benefits of tiotropium in asthmatics and in patients with asthma complicated chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 546s
Year: 2007

Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV1 in patients with severe persistent allergic asthma irrespective of age
Source: Eur Respir J 2005; 26: Suppl. 49, 48s
Year: 2005

Predictors of severe exacerbations in patients with moderate and severe asthma
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018



Benefits of pulmonary rehabilitation program in patients with persistent asthma
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018



Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017

Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017


Effects of exercise in patients with moderate to severe asthma
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008

Effects of pulmonary rehabilitation in the management of moderate COPD adults
Source: Eur Respir J 2004; 24: Suppl. 48, 518s
Year: 2004

Evaluating the efficacy of omalizumab in severe persistent asthma patients
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017

Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017


How frequent is bronchodilator reversibility in patients with stable asthma bronchiale and chronic obstructive lung disease (COPD) receiving maintenance therapy?
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012